BitcoinWorld Asia FX, Dollar Steady as Iran Ceasefire Uncertainty Lingers; China PMI Data Mixed Asian currencies and the US dollar traded in a narrow range onBitcoinWorld Asia FX, Dollar Steady as Iran Ceasefire Uncertainty Lingers; China PMI Data Mixed Asian currencies and the US dollar traded in a narrow range on

Asia FX, Dollar Steady as Iran Ceasefire Uncertainty Lingers; China PMI Data Mixed

2026/06/01 14:30
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

BitcoinWorld

Asia FX, Dollar Steady as Iran Ceasefire Uncertainty Lingers; China PMI Data Mixed

Asian currencies and the US dollar traded in a narrow range on Monday as markets remained cautious amid ongoing uncertainty surrounding a potential ceasefire between Iran and its adversaries. The lack of clear progress in diplomatic talks kept investors on edge, while a mixed reading of China’s manufacturing and services activity added to the subdued tone.

Iran Ceasefire Talks Stall, Weighing on Sentiment

Negotiations aimed at de-escalating tensions in the Middle East have yet to produce a definitive breakthrough, leaving traders reluctant to take aggressive positions. The uncertainty has capped gains for risk-sensitive currencies in Asia, while the dollar has also struggled to find direction as markets weigh the potential for supply disruptions versus a broader geopolitical de-escalation. Analysts note that any sudden shift in the diplomatic landscape could trigger sharp moves in currency pairs tied to oil prices, such as the Japanese yen and the Singapore dollar.

China’s Mixed PMI Data Adds to Caution

China’s latest Purchasing Managers’ Index (PMI) figures presented a contrasting picture of the world’s second-largest economy. The official manufacturing PMI edged higher, suggesting some resilience in factory output, but the services PMI slipped, reflecting persistent weakness in domestic demand. This mixed data has left investors questioning the strength of China’s post-pandemic recovery, further dampening enthusiasm for Asian currencies like the offshore yuan and the Australian dollar, which is often used as a proxy for China-related trade.

Implications for Regional Central Banks

The combination of geopolitical uncertainty and uneven economic data is likely to keep regional central banks cautious. The People’s Bank of China may face renewed pressure to implement additional stimulus measures to support growth, while other central banks in the region will be watching the dollar’s trajectory closely. A sustained period of dollar weakness could provide some relief for emerging Asian currencies, but the current environment of uncertainty is preventing any clear trend from emerging.

Conclusion

With the Iran ceasefire situation unresolved and China’s economic signals remaining mixed, Asian currency markets are likely to remain range-bound in the near term. Traders will be closely watching for any diplomatic breakthroughs or further economic data from China that could provide clearer direction. For now, caution prevails.

FAQs

Q1: Why are Asian currencies subdued today?
Asian currencies are subdued due to uncertainty over a potential Iran ceasefire and mixed economic data from China, which have made investors cautious.

Q2: How does the Iran situation affect currency markets?
The Iran situation creates uncertainty about oil supply and geopolitical stability, which can impact risk sentiment and currency valuations, especially for oil-sensitive currencies.

Q3: What does China’s mixed PMI data mean for the economy?
The mixed PMI data indicates that while manufacturing is showing some resilience, the services sector is weakening, suggesting an uneven economic recovery that may require further policy support.

This post Asia FX, Dollar Steady as Iran Ceasefire Uncertainty Lingers; China PMI Data Mixed first appeared on BitcoinWorld.

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage